Literature DB >> 11883868

Pituitary carcinoma: report of an exceptional case and review of the literature.

C Pichard1, S Gerber, M Laloi, M Kujas, S Clemenceau, D Ponvert, E Bruckert, G Turpin.   

Abstract

Pituitary carcinomas are exceptional tumors and constitute 0.1 to 0.2% of pituitary tumors. Their definition includes well-established criteria but distant metastasis is the hallmark required for diagnosis. We report the fourth case of gonadotropic pituitary carcinoma described in the literature. This case illustrates the dramatic outcome of these tumors. The most interesting feature of our case was the loss of differentiation with time, established by retrospective analysis of the primary tumor surgically treated 15 years earlier. Most of the previously reported cases exhibited a majority of adrenocoticotropin and non-functioning pituitary tumors. However, the frequency of non-functioning tumors seems smaller than previously believed. In the discussion, we stress the need to detect these very aggressive tumors as early as possible and identify treatments to improve the dramatic course of these carcinomas.

Entities:  

Mesh:

Year:  2002        PMID: 11883868     DOI: 10.1007/BF03343963

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

Review 1.  Metastatic adenocarcinoma in cerebral astrocytoma: clinicopathological and immunohistochemical study with review of the literature.

Authors:  Y Tajika; G Reifenberger; J C Kiwit; W Wechsler
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

2.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

3.  Metastases from a pituitary adenoma: MRI.

Authors:  L De Boucaud; V Dousset; P Caillaud; B Viaud; J Guerin; J M Caillé
Journal:  Neuroradiology       Date:  1999-10       Impact factor: 2.804

4.  ACTH-producing pituitary cancer: experience at the King Faisal Specialist Hospital & Research Centre.

Authors:  M Ahmed; I Kanaan; A Alarifi; E Ba-Essa; M Saleem; A Tulbah; P McArthur; R Hessler
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

Review 5.  Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.

Authors:  R B Mountcastle; B S Roof; R K Mayfield; D B Mordes; J Sagel; P J Biggs; S E Rawe
Journal:  Am J Med Sci       Date:  1989-08       Impact factor: 2.378

Review 6.  Intracranial and spinal dissemination of an ACTH secreting pituitary neoplasia. Case report and review of the literature.

Authors:  S Della Casa; S M Corsello; M A Satta; C A Rota; P Putignano; V Vangeli; C Colosimo; C Anile; A Barbarino
Journal:  Ann Endocrinol (Paris)       Date:  1997       Impact factor: 2.478

7.  Prolactin secreting pituitary carcinoma.

Authors:  T Petterson; I A MacFarlane; J M MacKenzie; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

8.  Gonadotropic pituitary carcinoma: case report.

Authors:  P Beauchesne; J Trouillas; F Barral; J Brunon
Journal:  Neurosurgery       Date:  1995-10       Impact factor: 4.654

9.  Pituitary Carcinomas.

Authors:  Wolfgang Saeger; Dorothee Lubke
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

Review 10.  Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan.

Authors:  Y Greenman; P Woolf; J Coniglio; R O'Mara; L Pei; J W Said; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

View more
  9 in total

Review 1.  Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review.

Authors:  Frederick Yoo; Edward C Kuan; Anthony P Heaney; Marvin Bergsneider; Marilene B Wang
Journal:  Pituitary       Date:  2018-06       Impact factor: 4.107

Review 2.  Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Authors:  Nèle Lenders; Ann McCormack
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

Review 3.  Pituitary carcinoma: diagnosis and treatment.

Authors:  M Beatriz S Lopes; Bernd W Scheithauer; David Schiff
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

4.  Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report.

Authors:  Sanjit Shah; Saima Manzoor; Yehudit Rothman; Matthew Hagen; Luke Pater; Karl Golnik; Abdelkader Mahammedi; Andrew L Lin; Ruchi Bhabhra; Jonathan A Forbes; Soma Sengupta
Journal:  Neurosurgery       Date:  2022-05-13       Impact factor: 5.315

Review 5.  Best Practice No 172: pituitary gland pathology.

Authors:  J W Ironside
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

Review 6.  Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.

Authors:  Agatha A van der Klaauw; Tina Kienitz; Christian J Strasburger; Johannes W A Smit; Johannes A Romijn
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Extremely late development of pituitary carcinoma after surgery and radiotherapy.

Authors:  Eberval Gadelha Figueiredo; Wellingson Silva Paiva; Manoel Jacobsen Teixeira
Journal:  J Neurooncol       Date:  2008-11-26       Impact factor: 4.130

8.  Overexpression of microRNA-34a Attenuates Proliferation and Induces Apoptosis in Pituitary Adenoma Cells via SOX7.

Authors:  Zijiang Yang; Ting Zhang; Qiping Wang; Heng Gao
Journal:  Mol Ther Oncolytics       Date:  2018-07-09       Impact factor: 7.200

9.  Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?

Authors:  Bastiaan Sol; Jeroen M K de Filette; Gil Awada; Steven Raeymaeckers; Sandrine Aspeslagh; C E Andreescu; Bart Neyns; Brigitte Velkeniers
Journal:  Eur J Endocrinol       Date:  2021-01       Impact factor: 6.664

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.